MindWalk Holdings (HYFT) Research & Development (2020 - 2026)
MindWalk Holdings (HYFT) reported Research & Development of $874771.6 for Q1 2026, up 35.87% year-over-year from $643846.1 in Q1 2025, and down 0.94% quarter-over-quarter from $883076.8 in Q4 2025.
MindWalk Holdings (HYFT) Research & Development (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Research & Development data on file, last reported at $874771.6 in Q1 2026.
- Research & Development for Q1 2026 came in at $874771.6, up 35.87% year-over-year; the trailing twelve-month figure through Jan 2026 was $1.8 million (down 99.84% YoY), and the FY2025 annual result was $3548.5, down 99.88% from the prior year.
- Research & Development eased to $874771.6 in Q1 2026 per HYFT's latest filing, from $883076.8 in the prior quarter.
- Over five years, Research & Development peaked at $1.1 billion in Q3 2024 and troughed at $885.44 in Q2 2025.
- A 5-year average of $106.7 million and a median of $764781.2 in 2023 frame the typical range for Research & Development.
- The sharpest annual moves came in 2023 and 2025: Research & Development jumped 15792617.46% in 2023, then tumbled 100.0% in 2025.
- A 5-year view of Research & Development shows it stood at $3.8 million in 2022, then slumped by 79.69% to $764781.2 in 2023, then retreated by 3.67% to $736682.4 in 2024, then advanced by 19.87% to $883076.8 in 2025, then retreated by 0.94% to $874771.6 in 2026.
- Business Quant data shows HYFT's Research & Development at $874771.6 in Q1 2026, $883076.8 in Q4 2025, and $1083.7 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -58.00 Mn |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | 874,771.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 874,771.62 |
| Oct 31, 2025 | 883,076.78 |
| Jul 31, 2025 | 1,083.67 |
| Apr 30, 2025 | 885.44 |
| Jan 31, 2025 | 643,846.14 |
| Oct 31, 2024 | 736,682.43 |
| Jul 31, 2024 | 1.09 Bn |
| Apr 30, 2024 | 929,275.55 |
| Jan 31, 2024 | 740,461.20 |
| Oct 31, 2023 | 764,781.16 |
| Jul 31, 2023 | 709.50 Mn |
| Apr 30, 2023 | 674,012.85 |
| Jan 31, 2023 | 1.16 Mn |
| Oct 31, 2022 | 3.77 Mn |
| Jul 31, 2022 | 4,492.55 |
| Apr 30, 2022 | 6.05 Mn |
| Jan 31, 2022 | 1,437.95 |
| Oct 31, 2021 | 2,265.41 |
| Jul 31, 2021 | 910,847.02 |
| Apr 30, 2021 | 488,867.10 |